|
1008
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
NDC00548-1008-00
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
1008
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
NDC00548-1008-00
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
1008
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
NDC00548-1008-00
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
1008
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
NDC00548-1008-00
|
6505-01-153-3866
|
Usp Aminophylline Injection |
International Medication Systems,
|
|
Quote
|
|
ISOPTO CARPINE
|
6505-01-153-3869
|
Pilocarpine Hydrochloride Ophtha |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO CARPINE DROPS
|
6505-01-153-3869
|
Pilocarpine Hydrochloride Ophtha |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00998-0209-15
|
6505-01-153-3869
|
Pilocarpine Hydrochloride Ophtha |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0209-15
|
6505-01-153-3869
|
Pilocarpine Hydrochloride Ophtha |
Alcon Laboratories, Inc.
|
|
Quote
|
|
CRESYLATE
|
6505-01-153-3877
|
Cresyl Acetate Otic Solution |
Recsei Laboratories Llc
|
|
Quote
|
|
NDC10952-0035-13
|
6505-01-153-3877
|
Cresyl Acetate Otic Solution |
Recsei Laboratories Llc
|
|
Quote
|
|
NDC52544-0044-24
|
6505-01-153-3883
|
Usp Flurandrenolide Tape |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
NDC52544-0044-24
|
6505-01-153-3883
|
Usp Flurandrenolide Tape |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
NDC52544-0044-24
|
6505-01-153-3883
|
Usp Flurandrenolide Tape |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
NDC52544-0044-24
|
6505-01-153-3883
|
Usp Flurandrenolide Tape |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
COUMADIN
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN TABLETS
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
NDC00056-0173-70
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN TABLETS
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
NDC00056-0173-70
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN TABLETS
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
NDC00056-0173-70
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN TABLETS
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
COUMADIN
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
NDC00056-0173-70
|
6505-01-153-3886
|
Usp Warfarin Sodium Tablets |
Bristol-myers Squibb Pharma Company
|
|
Quote
|
|
CREAM BASE
|
6505-01-153-3889
|
Cream Base |
Medco Lab Inc
|
|
Quote
|
|
NDC11940-3313-06
|
6505-01-153-3889
|
Cream Base |
Medco Lab Inc
|
|
Quote
|
|
NDC00062-1411-23
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
MICRONOR
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
NDC00062-1411-23
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
MICRONOR
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
NDC00062-1411-23
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
MICRONOR
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
NDC00062-1411-23
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
MICRONOR
|
6505-01-153-3897
|
Usp Norethindrone Tablets |
Ortho Pharmaceutical Corp
|
|
Quote
|
|
PEPTO-BISMOL LIQUID
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Distributing Llc,
|
|
Quote
|
|
NDC00149-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC01490-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Microtech, Inc.
|
|
Quote
|
|
PEPTO-BISMOL LIQUID
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Distributing Llc,
|
|
Quote
|
|
NDC01490-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Microtech, Inc.
|
|
Quote
|
|
NDC00149-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
PEPTO-BISMOL LIQUID
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Distributing Llc,
|
|
Quote
|
|
NDC01490-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Microtech, Inc.
|
|
Quote
|
|
NDC00149-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
PEPTO-BISMOL LIQUID
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Procter & Gamble Distributing Llc,
|
|
Quote
|
|
NDC01490-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Microtech, Inc.
|
|
Quote
|
|
NDC00149-0039-08
|
6505-01-153-3909
|
Bismuth Subsalicylate Suspension |
Cardinal Health 200, Llc
|
|
Quote
|
|
HALOG SOLUTION
|
6505-01-153-3935
|
Usp Halcinonide Topical Solution |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0249-15
|
6505-01-153-3935
|
Usp Halcinonide Topical Solution |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0249-15
|
6505-01-153-3935
|
Usp Halcinonide Topical Solution |
Squibb E R and Sons Inc
|
|
Quote
|
|
MITHRACIN
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-8161-15
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-8161-15
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
MITHRACIN
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-8161-15
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
MITHRACIN
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-8161-15
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
MITHRACIN
|
6505-01-153-3938
|
Usp Plicamycin For Injection |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
K-PHOS NEUTRAL
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1125-01
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
K-PHOS NEUTRAL
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1125-01
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
K-PHOS NEUTRAL
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1125-01
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
K-PHOS NEUTRAL
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1125-01
|
6505-01-153-3939
|
Potassium Phosphate And Sodium P |
Beach Products Inc
|
|
Quote
|
|
MEDEVA PHARM
|
6505-01-153-3957
|
Usp Metolazone Tablets |
Defense Logistics Agency
|
|
Quote
|
|
ZAROXOLYN
|
6505-01-153-3957
|
Usp Metolazone Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC53014-0835-71
|
6505-01-153-3957
|
Usp Metolazone Tablets |
Ucb Manufacturing Inc.
|
|
Quote
|
|
NDC53014-0835-71
|
6505-01-153-3957
|
Usp Metolazone Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00585-0835-71
|
6505-01-153-3957
|
Usp Metolazone Tablets |
Fisons Corp
|
|
Quote
|
|
NDC00585-0835-71
|
6505-01-153-3957
|
Usp Metolazone Tablets |
Defense Logistics Agency
|
|
Quote
|
|
ARTANE
|
6505-01-153-3963
|
Trihexyphenidyl Hydrochloride Ta |
American Cyanamid Co
|
|
Quote
|
|
ARTANE TABLETS
|
6505-01-153-3963
|
Trihexyphenidyl Hydrochloride Ta |
American Cyanamid Co
|
|
Quote
|
|
NDC00603-6240-32
|
6505-01-153-3963
|
Trihexyphenidyl Hydrochloride Ta |
Generics Bidco I, Llc
|
|
Quote
|
|
NDC52544-0575-10
|
6505-01-153-3963
|
Trihexyphenidyl Hydrochloride Ta |
Watson Labs Inc
|
|
Quote
|
|
NDC00005-4434-34
|
6505-01-153-3963
|
Trihexyphenidyl Hydrochloride Ta |
American Cyanamid Co
|
|
Quote
|
|
CAPASTAT SULFATE
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
718
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Dura Pharmaceuticals Inc
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1485-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
CAPASTAT SULFATE
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
718
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Dura Pharmaceuticals Inc
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1485-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
CAPASTAT SULFATE
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
718
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Dura Pharmaceuticals Inc
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1485-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
CAPASTAT SULFATE
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
718
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Dura Pharmaceuticals Inc
|
|
Quote
|
|
NDC51479-0018-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-1485-01
|
6505-01-153-3966
|
Usp Capreomycin Sulfate |
Eli Lilly and Company
|
|
Quote
|
|
SUDAFED
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED TABLETS
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0865-78
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED TABLETS
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0865-78
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED TABLETS
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0865-78
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
SUDAFED TABLETS
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0865-78
|
6505-01-153-3967
|
Pseudoephedrine Hydrochloride Ta |
Burroughs Wellcome Co
|
|
Quote
|
|
FLEX-CARE
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0158-12
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
FLEX-CARE
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0158-12
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
FLEX-CARE
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0158-12
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
FLEX-CARE
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00065-0158-12
|
6505-01-153-3969
|
Contact Lens Disinfecting And Ri |
Alcon Laboratories, Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
LEVSINEX TIMECAPS
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC00091-3537-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC00998-2260-10
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
LEVSINEX TIMECAPS
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00091-3537-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories, Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC00998-2260-10
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
LEVSINEX TIMECAPS
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00091-3537-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories, Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC00998-2260-10
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
LEVSINEX TIMECAPS
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC00091-3537-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Schwarz Pharma Inc.
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories, Inc.
|
|
Quote
|
|
CYSTOSPAZ-M
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC00998-2260-10
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC61451-2260-01
|
6505-01-153-3982
|
Hyoscyamine Sulfate Extended-rel |
Alcon Laboratories Inc
|
|
Quote
|
|
NDC60432-0613-04
|
6505-01-153-3984
|
Furosemide Oral Solution |
Morton Grove Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00054-3294-50
|
6505-01-153-3984
|
Furosemide Oral Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC60432-0613-04
|
6505-01-153-3984
|
Furosemide Oral Solution |
Morton Grove Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00054-3294-50
|
6505-01-153-3984
|
Furosemide Oral Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC60432-0613-04
|
6505-01-153-3984
|
Furosemide Oral Solution |
Morton Grove Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00054-3294-50
|
6505-01-153-3984
|
Furosemide Oral Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC60432-0613-04
|
6505-01-153-3984
|
Furosemide Oral Solution |
Morton Grove Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00054-3294-50
|
6505-01-153-3984
|
Furosemide Oral Solution |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
HYPOTEARS
|
6505-01-153-4014
|
Artificial Tears Solution |
Cooper Laboratories Inc
|
|
Quote
|
|
HYPOTEARS SOLUTION
|
6505-01-153-4014
|
Artificial Tears Solution |
Iolab Corp
|
|
Quote
|
|
NDC58768-0130-15
|
6505-01-153-4014
|
Artificial Tears Solution |
Novartis Ophthalmics Inc.
|
|
Quote
|
|
HYPOTEARS SOLUTION
|
6505-01-153-4014
|
Artificial Tears Solution |
Iolab Corp
|
|
Quote
|
|
NDC58768-0130-15
|
6505-01-153-4014
|
Artificial Tears Solution |
Novartis Ophthalmics Inc.
|
|
Quote
|
|
HYPOTEARS
|
6505-01-153-4014
|
Artificial Tears Solution |
Cooper Laboratories Inc
|
|
Quote
|
|
HYPOTEARS SOLUTION
|
6505-01-153-4014
|
Artificial Tears Solution |
Iolab Corp
|
|
Quote
|
|
NDC58768-0130-15
|
6505-01-153-4014
|
Artificial Tears Solution |
Novartis Ophthalmics Inc.
|
|
Quote
|
|
HYPOTEARS
|
6505-01-153-4014
|
Artificial Tears Solution |
Cooper Laboratories Inc
|
|
Quote
|
|
HYPOTEARS SOLUTION
|
6505-01-153-4014
|
Artificial Tears Solution |
Iolab Corp
|
|
Quote
|
|
NDC58768-0130-15
|
6505-01-153-4014
|
Artificial Tears Solution |
Novartis Ophthalmics Inc.
|
|
Quote
|
|
HYPOTEARS
|
6505-01-153-4014
|
Artificial Tears Solution |
Cooper Laboratories Inc
|
|
Quote
|
|
POLYCITRA
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA SYRUP
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
NDC00121-0677-16
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Pharmaceutical Associates, Inc.
|
|
Quote
|
|
NDC17314-9322-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Alza Corp
|
|
Quote
|
|
NDC00575-0223-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA SYRUP
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
NDC00121-0677-16
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Pharmaceutical Associates, Inc.
|
|
Quote
|
|
NDC17314-9322-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Alza Corp
|
|
Quote
|
|
NDC00575-0223-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA SYRUP
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
NDC00121-0677-16
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Pharmaceutical Associates, Inc.
|
|
Quote
|
|
NDC17314-9322-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Alza Corp
|
|
Quote
|
|
NDC00575-0223-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
POLYCITRA SYRUP
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
NDC00121-0677-16
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Pharmaceutical Associates, Inc.
|
|
Quote
|
|
NDC17314-9322-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Alza Corp
|
|
Quote
|
|
NDC00575-0223-01
|
6505-01-153-4026
|
Usp Tricitrates Oral Solution |
Willen Drug Co
|
|
Quote
|
|
NDC00264-1167-90
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
S9135
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
NDC00264-1167-90
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
S9135
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
NDC00264-1167-90
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
S9135
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
NDC00264-1167-90
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
S9135
|
6505-01-153-4048
|
Hyperalimentation Kit |
B Braun Medical Inc
|
|
Quote
|
|
96-0457
|
6505-01-153-4059
|
Collagenase Ointment |
Defense Logistics Agency
|
|
Quote
|
|
NDC00064-5010-30
|
6505-01-153-4059
|
Collagenase Ointment |
Healthpoint Ltd
|
|
Quote
|
|
96-0457
|
6505-01-153-4059
|
Collagenase Ointment |
Defense Logistics Agency
|
|
Quote
|
|
NDC00064-5010-30
|
6505-01-153-4059
|
Collagenase Ointment |
Healthpoint Ltd
|
|
Quote
|
|
96-0457
|
6505-01-153-4059
|
Collagenase Ointment |
Defense Logistics Agency
|
|
Quote
|
|
NDC00064-5010-30
|
6505-01-153-4059
|
Collagenase Ointment |
Healthpoint Ltd
|
|
Quote
|
|
96-0457
|
6505-01-153-4059
|
Collagenase Ointment |
Defense Logistics Agency
|
|
Quote
|
|
NDC00064-5010-30
|
6505-01-153-4059
|
Collagenase Ointment |
Healthpoint Ltd
|
|
Quote
|
|
NDC52152-0015-02
|
6505-01-153-4066
|
Dexchlorpheniramine Maleate Exte |
Amide Pharmaceutical Inc
|
|
Quote
|
|
OVCON-50
|
6505-01-153-4068
|
Norethindrone And Ethinyl Estrad |
Mead Johnson & Company, Llc
|
|
Quote
|
|
OVCON-50 TABLETS
|
6505-01-153-4068
|
Norethindrone And Ethinyl Estrad |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0579-41
|
6505-01-153-4068
|
Norethindrone And Ethinyl Estrad |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0579-41
|
6505-01-153-4068
|
Norethindrone And Ethinyl Estrad |
Bristol-myers Squibb Company
|
|
Quote
|
|
TRIDESILON
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
The Bayer Co
|
|
Quote
|
|
NDC51672-1281-01
|
6505-01-153-4092
|
Desonide Ointment |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
TRIDESILON OINTMENT
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC51672-1281-01
|
6505-01-153-4092
|
Desonide Ointment |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
TRIDESILON
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
The Bayer Co
|
|
Quote
|
|
TRIDESILON OINTMENT
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC51672-1281-01
|
6505-01-153-4092
|
Desonide Ointment |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
|
TRIDESILON
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
The Bayer Co
|
|
Quote
|
|
TRIDESILON OINTMENT
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC51672-1281-01
|
6505-01-153-4092
|
Desonide Ointment |
Taro Pharmaceuticals Usa Inc
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
TRIDESILON
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00026-5591-61
|
6505-01-153-4092
|
Desonide Ointment |
The Bayer Co
|
|
Quote
|
|
TRIDESILON OINTMENT
|
6505-01-153-4092
|
Desonide Ointment |
Bayer Pharmaceuticals Corporation
|
|
Quote
|
